Primus In News
How to ensure sustainability and wider stakeholder acceptability in NLEM revisions
07-12-2022
Nilaya Varma, CEO and Managing Director, Primus Partners shares his thoughts on the 4th revision of the National List of Essential Medicines, in particular releasing frequent revisions to the list as well as providing greater financial incentives to pharma companies.
Explore Related Insights
- Addressing Sectoral Challenges Through Digital Transformation: Leveraging AI and Data Analytics in Agriculture
- Addressing Sectoral Challenges Through Digital Transformation to leverage AI and Data Analytics in Agriculture
- Monthly Sector Update | Technology | November 2020
- Monthly Sector Update | Power | September 2020
